Literature DB >> 34550244

Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis - 2021.

Marcus V Simões1, Fabio Fernandes2, Fabiana G Marcondes-Braga2, Philip Scheinberg3, Edileide de Barros Correia4, Luis Eduardo P Rohde5,6,7, Fernando Bacal2, Silvia Marinho Martins Alves8,9, Sandrigo Mangini2, Andréia Biolo5, Luis Beck-da-Silva5,7, Roberta Shcolnik Szor10,11, Wilson Marques Junior1, Acary Souza Bulle Oliveira12, Márcia Waddington Cruz13, Bruno Vaz Kerges Bueno14, Ludhmila Abrahão Hajjar2,11, Aurora Felice Castro Issa15, Felix José Alvarez Ramires2,16, Otavio Rizzi Coelho Filho17, André Schmidt1, Ibraim Masciarelli Francisco Pinto18, Carlos Eduardo Rochitte2,19,20, Marcelo Luiz Campos Vieira2,16, Cláudio Tinoco Mesquita21, Celso Dario Ramos17, José Soares-Junior2, Minna Moreira Dias Romano1, Wilson Mathias Junior1, Marcelo Iório Garcia Junior13, Marcelo Westerlund Montera20, Marcelo Dantas Tavares de Melo22, Sandra Marques E Silva23, Pedro Manoel Marques Garibaldi1, Aristóteles Comte de Alencar Neto2, Renato Delascio Lopes24, Diane Xavier de Ávila20,25,26,27, Denizar Viana28, José Francisco Kerr Saraiva29, Manoel Fernandes Canesin30, Glaucia Maria Moraes de Oliveira31, Evandro Tinoco Mesquita21,32.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34550244      PMCID： PMC8462947          DOI： 10.36660/abc.20210718

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN： 0066-782X            Impact factor:   2.000


× No keyword cloud information.
  202 in total

1.  Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging.

Authors:  Jens-Uwe Voigt; Gianni Pedrizzetti; Peter Lysyansky; Tom H Marwick; Hélène Houle; Rolf Baumann; Stefano Pedri; Yasuhiro Ito; Yasuhiko Abe; Stephen Metz; Joo Hyun Song; Jamie Hamilton; Partho P Sengupta; Theodore J Kolias; Jan d'Hooge; Gerard P Aurigemma; James D Thomas; Luigi Paolo Badano
Journal:  J Am Soc Echocardiogr       Date:  2015-02       Impact factor: 5.251

2.  Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.

Authors:  François-Pierre Mongeon; Michael Jerosch-Herold; Otávio Rizzi Coelho-Filho; Ron Blankstein; Rodney H Falk; Raymond Y Kwong
Journal:  JACC Cardiovasc Imaging       Date:  2012-09

3.  Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis.

Authors:  Edward A El-Am; Angela Dispenzieri; Rowlens M Melduni; Naser M Ammash; Roger D White; David O Hodge; Peter A Noseworthy; Grace Lin; Sorin V Pislaru; Alexander C Egbe; Martha Grogan; Vuyisile T Nkomo
Journal:  J Am Coll Cardiol       Date:  2019-02-12       Impact factor: 24.094

4.  CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis.

Authors:  James A White; Han W Kim; Dipan Shah; Nowell Fine; Ki-Young Kim; David C Wendell; Wael Al-Jaroudi; Michele Parker; Manesh Patel; Femida Gwadry-Sridhar; Robert M Judd; Raymond J Kim
Journal:  JACC Cardiovasc Imaging       Date:  2014-01-08

5.  Role of ventricular assist therapy for patients with heart failure and restrictive physiology: Improving outcomes for a lethal disease.

Authors:  Avishay Grupper; Soon J Park; Naveen L Pereira; Sarah D Schettle; Yariv Gerber; Yan Topilsky; Brooks S Edwards; Richard C Daly; John M Stulak; Lyle D Joyce; Sudhir S Kushwaha
Journal:  J Heart Lung Transplant       Date:  2015-03-26       Impact factor: 10.247

Review 6.  Systemic amyloidosis from A (AA) to T (ATTR): a review.

Authors:  E Muchtar; A Dispenzieri; H Magen; M Grogan; M Mauermann; E D McPhail; P J Kurtin; N Leung; F K Buadi; D Dingli; S K Kumar; M A Gertz
Journal:  J Intern Med       Date:  2020-09-14       Impact factor: 8.989

7.  Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival.

Authors:  Christopher P Venner; Thirusha Lane; Darren Foard; Lisa Rannigan; Simon D J Gibbs; Jennifer H Pinney; Carol J Whelan; Helen J Lachmann; Julian D Gillmore; Philip N Hawkins; Ashutosh D Wechalekar
Journal:  Blood       Date:  2012-02-13       Impact factor: 22.113

8.  Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study.

Authors:  Sanjay M Banypersad; Daniel M Sado; Andrew S Flett; Simon D J Gibbs; Jennifer H Pinney; Viviana Maestrini; Andrew T Cox; Marianna Fontana; Carol J Whelan; Ashutosh D Wechalekar; Philip N Hawkins; James C Moon
Journal:  Circ Cardiovasc Imaging       Date:  2012-11-28       Impact factor: 7.792

9.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Authors:  Julian D Gillmore; Mathew S Maurer; Rodney H Falk; Giampaolo Merlini; Thibaud Damy; Angela Dispenzieri; Ashutosh D Wechalekar; John L Berk; Candida C Quarta; Martha Grogan; Helen J Lachmann; Sabahat Bokhari; Adam Castano; Sharmila Dorbala; Geoff B Johnson; Andor W J M Glaudemans; Tamer Rezk; Marianna Fontana; Giovanni Palladini; Paolo Milani; Pierluigi L Guidalotti; Katarina Flatman; Thirusha Lane; Frederick W Vonberg; Carol J Whelan; James C Moon; Frederick L Ruberg; Edward J Miller; David F Hutt; Bouke P Hazenberg; Claudio Rapezzi; Philip N Hawkins
Journal:  Circulation       Date:  2016-04-22       Impact factor: 29.690

Review 10.  Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.

Authors:  Yoshiki Sekijima; Mitsuharu Ueda; Haruki Koike; Sonoko Misawa; Tomonori Ishii; Yukio Ando
Journal:  Orphanet J Rare Dis       Date:  2018-01-17       Impact factor: 4.123
View more
  3 in total

1.  Cardiac amyloidosis in Latin America: Gaps and opportunities to increase awareness of the disease. Findings from the AMILO-LATAM research group.

Authors:  Fernando Mut; Isabel Carvajal; Jorge Camilletti; Juan Erriest; Erick Alexanderson; Gabriel Blacher Grossman
Journal:  J Nucl Cardiol       Date:  2022-05-31       Impact factor: 3.872

2.  Amyloidosis for Cardiologists.

Authors:  Roberto Coury Pedrosa
Journal:  Arq Bras Cardiol       Date:  2022-02       Impact factor: 2.000

3.  Utility of Biomarkers in Suspected Cardiac Amyloidosis: Opportunity for More Frequent and Early Diagnosis.

Authors:  João Marcos Barbosa-Ferreira; Andreza Araújo de Oliveira
Journal:  Arq Bras Cardiol       Date:  2022-08       Impact factor: 2.667
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.